GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (TSX:AVCN) » Definitions » Current Deferred Taxes Liabilities

Avicanna (TSX:AVCN) Current Deferred Taxes Liabilities : C$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Avicanna Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Avicanna's current deferred tax liabilities for the quarter that ended in Dec. 2023 was C$0.00 Mil.

Avicanna Current Deferred Taxes Liabilities Historical Data

The historical data trend for Avicanna's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avicanna Current Deferred Taxes Liabilities Chart

Avicanna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial - - - - -

Avicanna Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Avicanna Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Avicanna's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Avicanna (TSX:AVCN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (TSX:AVCN) » Definitions » Current Deferred Taxes Liabilities
Comparable Companies
TSXV:PCLO XCNQ:TIUM.U TSXV:CANB TSXV:LSL XCNQ:GDNS TSX:LABS XCNQ:ACRG.A.U TSX:AVNT XCNQ:BNXT XCNQ:CXXI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
AVCNF:USA 0NN:Germany
Address
480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2
Website
https://www.avicanna.com
Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.
Executives
Sheldon Inwentash 10% Security Holder

Avicanna (TSX:AVCN) Headlines

No Headlines